Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scleroderma epidemiology

M D Mayes1

  • 1Wayne State University School of Medicine, Detroit, Michigan, USA.

Rheumatic Diseases Clinics of North America
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Scleroderma incidence and prevalence in the US remain stable. Black women face higher rates and more diffuse disease, with genetics and environmental factors influencing causation and survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.

Medicine·2016
Same author

Association of HLA-DQB1*0501 with scleroderma and its clinical features in Chinese population.

International journal of immunopathology and pharmacology·2013
Same author

STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population.

International journal of immunopathology and pharmacology·2013
Same author

Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis.

Arthritis and rheumatism·2012
Same author

Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis.

Annals of the rheumatic diseases·2010
Same author

BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians.

Annals of the rheumatic diseases·2009
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Area of Science:

  • Rheumatology
  • Epidemiology
  • Immunogenetics

Background:

  • Scleroderma, a chronic autoimmune disease, affects skin and internal organs.
  • Understanding scleroderma epidemiology is crucial for public health and patient care.

Purpose of the Study:

  • To analyze trends in scleroderma incidence and prevalence in the United States over two decades.
  • To identify demographic and clinical risk factors for disease development and survival.

Main Methods:

  • Analysis of epidemiological data on scleroderma incidence and prevalence.
  • Examination of age-specific incidence rates across different racial groups.
  • Identification of risk factors for disease onset and prognosis.

Main Results:

Related Experiment Videos

  • Overall scleroderma rates in the US have been stable for 20 years.
  • Black women exhibit higher age-specific incidence and more diffuse disease compared to white women.
  • Female gender and HLA-DQ type are potential risk factors for scleroderma; diffuse disease, older age at onset, and early organ involvement predict poorer survival.

Conclusions:

  • Scleroderma epidemiology is relatively stable, but disparities exist among racial groups.
  • Genetic predisposition and environmental triggers likely interact in scleroderma pathogenesis.
  • Identifying risk factors is key to improving outcomes for scleroderma patients.